INDEGENE LTDII

INDEGENE LTD

541.40INRR
−14.15−2.55%
At close at 10:11 GMT
INR
No trades
See on Supercharts

INDGN fundamentals

Key facts

Market capitalization‪132.77 B‬INR
Founded2009
CEOManish Gupta
About

Indegene Ltd. engages in the provision of healthcare support, media, and technology services to the pharmaceutical and biotechnology sectors. It operates through Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation and Others segment. The Enterprise Medical Solutions segment establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. The Enterprise Commercial Solutions segment involves in assisting life sciences companies with their digital marketing operations. The Omnichannel Activation solutions segment helps life sciences companies to leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. The Others segment offers enterprise clinical solutions and consultancy services. The company was founded by Manish Gupta, Rajesh Bhaskaran Nair, Sanjay Suresh Parikh, Gaurav Kapoor, and Anand Kiran on October 16, 1998 and is headquartered in Bangalore, India.

Ownership
‪‪239.27 M‬‬
Closely held shares
‪‪180.96 M‬‬ (75.63%)
Free Float shares
‪‪58.31 M‬‬ (24.37%)
Closely held shares
‪‪180.96 M‬‬ (75.63%)
Free Float shares
‪‪58.31 M‬‬ (24.37%)
Capital structure
Market cap
‪‪132.77 B‬‬
Enterprise value
‪‪132.77 B‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪132.77 B‬‬
Price to earning ratio (P/E)
34.77x
Price to sales ratio (P/S)
4.86x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
34.77x
Price to sales ratio (P/S)
4.86x
Valuation ratios
‪0.00‬
‪1.50‬
‪3.00‬
‪4.50‬
‪6.00‬
Q4 '22
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪10.00‬
‪20.00‬
‪30.00‬
‪40.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪7.5%‬
‪9.5%‬
‪11.5%‬
‪13.5%‬
‪15.5%‬
Q4 '22
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2023
Enterprise Commercial Solutions
Enterprise Medical Solutions
Omnichannel Activation
Other
By country
Period: 2023
United States
Europe
Rest of the World
India
North America

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪‪2.00 B‬‬
‪‪4.00 B‬‬
‪‪6.00 B‬‬
‪‪8.00 B‬‬
Actual
Estimate
Earnings
Next:May 28, 2025
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪0.00‬
‪1.20‬
‪2.40‬
‪3.60‬
‪4.80‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

INDGN does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company

Debt level and coverage
Q4 '22
Q4 '23
Q1 '24
Q2 '24
Q3 '24
‪0.00‬
‪‪1.30 B‬‬
‪‪2.60 B‬‬
‪‪3.90 B‬‬
‪‪5.20 B‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
Assets
Liabilities